Osiris Therapeutics, Inc. (Pink Sheets: OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that a new peer reviewed manuscript entitled “Placental Membranes for Management of Refractory Cutaneous Sinus Tracts of Surgical Origin: A Pilot Study” has been published in The Journal of the American College of Clinical Wound Specialists and is available online.
{iframe}http://www.osiris.com/wp-content/uploads/2017/10/2017-10-05-Sinus-Tract-Pilot-Study-Johnson-Press-Release-FINAL.pdf{/iframe}